Publication: 4708

Publication: 4708

Development and Validation of a Novel Conditional Event‐Free Survival Tool in Diffuse Large B‐Cell Lymphoma

PubMed

PMC

QxMD

DOI

Google Scholar

Citation:: Am J Hematol vol 101 (9) 2137-46

Year:: 2026
Type:: Manuscript
Funding:: NCTN
Endpoint:: Primary
Analysis:: Primary
Data Sharing:: Alliance-data-source,-external-user
Status:: Presented/Published
Citation Status:: ppub

Note:

Methodological:: No
Biospecimen:: No
SDC:: No
Book Volume:

Parents:: 3835
Children:: None

Program:: OGC
Primary Committee:: Lymphoma
Sec. Committees:

Pharmas:
Grants:: U10CA180821, U10CA180882, UG1CA189961, UG1CA232760, UG1CA233247, UG1CA233329, UG1CA233339, UG1CA233373, P50CA97274 (MER), U01CA195568 (LEO), U10CA180820 (ECOG-ACRIN), U10CA180888 (SWOG), F2022-011 (LYFO)

Corr. Author:
Authors:: Zhengming Chen Danny Luan Rasmus Rask Kragh Jørgensen Lasse Jakobsen Matthew J. Maurer Tarec C. El‐Galaly Loretta J. Nastoupil James R. Cerhan Christopher R. Flowers Brian K. Link Izidore S. Lossos Deborah M. Stephens Jonathon Cohen Thomas M. Habermann Grzegorz Nowakowski Nancy Bartlett Jonathan W. Friedberg Brad S. Kahl John P. Leonard Peter Brown Karin E. Smedby Mats Jerkeman Peter Martin

Networks:: CORA, FL028, IA018, LAPS-MN026, LAPS-MO011, NC007, NY011, NY018, PA075

Study: Alliance-A152112
Multiple Studies, or Legacy Studies in Alliance Study:: CALGB-50303, ECOG-E1412, ECOG-E4494, SWOG-S1001
Phases:: N/A, 2, 3

Keywords: